| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,773 |
2,164 |
$623K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,395 |
995 |
$558K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
470 |
286 |
$209K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,558 |
1,834 |
$45K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
241 |
173 |
$40K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,209 |
1,412 |
$36K |
| 80053 |
Comprehensive metabolic panel |
1,457 |
1,060 |
$28K |
| 36415 |
Collection of venous blood by venipuncture |
2,891 |
2,020 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
289 |
200 |
$19K |
| 71045 |
Radiologic examination, chest; single view |
173 |
121 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
127 |
92 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
147 |
96 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
123 |
93 |
$7K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
43 |
38 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
343 |
175 |
$6K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
96 |
82 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
275 |
215 |
$5K |
| 81001 |
|
657 |
504 |
$4K |
| 0240U |
|
36 |
36 |
$3K |
| 84484 |
|
128 |
84 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
125 |
54 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
45 |
43 |
$2K |
| 83735 |
|
143 |
110 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15 |
12 |
$1K |
| 86140 |
|
86 |
69 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
91 |
64 |
$917.13 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
73 |
38 |
$470.63 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
18 |
$437.25 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
37 |
24 |
$379.78 |
| 85610 |
|
54 |
38 |
$355.29 |
| A9270 |
Non-covered item or service |
2,067 |
968 |
$230.59 |
| 87430 |
|
20 |
12 |
$191.07 |
| J3490 |
Unclassified drugs |
78 |
38 |
$96.44 |
| 99443 |
|
20 |
13 |
$66.07 |